Showing 1–12 of 36 results

CAS NO. PRODUCT NAME OVERVIEW
    935881-37-1 AR-42 (935881-37-1)

    AR-42 is a novel HDAC inhibitor, exhibits biologic activity against malignant mast cell lines via down-regulation of constitutively activated...

    844442-38-2 AT7519 (844442-38-2)

    AT7519 is an inhibitor of multiple cyclin-dependent kinases (CDKs), which may result in cell cycle arrest, induction of apoptosis, and inhibi...

    602306-29-6 AZD5438 (602306-29-6)

    AZD5438 is a potent inhibitor of CDK1/2/9 with IC50 of 16 nM/6 nM/20 nM. It is less potent to CDK5/6 and also inhibits GSK3β. Phase 1.

    865783-99-9 Briciclib (865783-99-9)

    Briciclib is a benzyl styryl sulfone analog, and a disodium phosphate ester prodrug of ON 013100, with potential antineoplastic activity.

    ...
    1421693-22-2 CDKI-73 (1421693-22-2)

    CDKI-73 is a potent CDK9 inhibitor with Ki of 4 nM. It shows selective toxicity to CLL cells(LD50=80 nM) versus normal B cell and normal CD34...

    199986-75-9 CVT-313 (NG-26) (199986-75-9)

    CVT-313 is a potent, selective, reversible, and ATP-competitive inhibitor of CDK2 (IC50 = 0.5 uM for Cdk2/A and Cdk2/E; 4.2 uM for Cdk1/B; 21...

    779353-01-4 Dinaciclib (SCH727965) (779353-01-4)

    Dinaciclib (SCH727965) is a novel and potent CDK inhibitor for CDK2, CDK5, CDK1 and CDK9 with IC50 of 1 nM, 1 nM, 3 nM and 4 nM, respectively...

    942918-07-2 GSK1070916 (942918-07-2)

    GSK1070916 is a potent Aurora B/C kinase inhibitor (with IC50 of 3.5 nM/6.5 nM) with broad antitumor activity in tissue culture cells and hum...

    1346546-69-7 GSK872 (1346546-69-7)

    GSK872 is a a receptor interacting protein kinase-3 (RIP3) inhibitor. GSK872 inhibits TNF- and virus-induced necrosis in 3T3-SA fibroblasts. ...

    443797-96-4 JNJ7706621 (443797-96-4)

    JNJ-7706621 is pan-CDK inhibitor with the highest potency on CDK1/2 with IC50 of 9 nM/4 nM and showing >6-fold selectivity for CDK1/2 than...

    1073485-20-7 LDC000067 (1073485-20-7)

    LDC000067 is a highly selective CDK9 inhibitor with IC50 of 44 nM, 55/125/210/ >227/ >227-fold selectivity over CDK2/1/4/6/7….

    1453834-21-3 LDC4297 (1453834-21-3)

    LDC4297 is a novel CDK7 inhibitor (IC50=0.13±0.06 nM for CDK7 versus IC50s between 10 nM and 10,000 nM for all other analyzed CDKs)..

    ...

1 2 3